Literature DB >> 23384596

Cancer stem cells and their role in metastasis.

Yusuke Shiozawa1, Biao Nie, Kenneth J Pienta, Todd M Morgan, Russell S Taichman.   

Abstract

Cancer stem cells (CSCs), which comprise a small fraction of cancer cells, are believed to constitute the origin of most human tumors. Considerable effort has been focused on identifying CSCs in multiple tumor types and identifying genetic signatures that distinguish CSCs from normal tissue stem cells. Many studies also suggest that CSCs serve as the basis of metastases. Yet, experimental evidence that CSCs are the basis of disseminated metastases has lagged behind the conceptual construct of CSCs. Recent work, however, has demonstrated that CSCs may directly or indirectly contribute to the generation of metastasis. Moreover, CSC heterogeneity may be largely responsible for the considerable complexity and organ specificity of metastases. In this review, we discuss the role of CSCs in metastasis and their potential as therapeutic targets.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23384596      PMCID: PMC3602306          DOI: 10.1016/j.pharmthera.2013.01.014

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  140 in total

1.  Re: Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.

Authors:  Anthony Atala
Journal:  J Urol       Date:  2012-02-17       Impact factor: 7.450

2.  Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients.

Authors:  Faiyaz Notta; Sergei Doulatov; John E Dick
Journal:  Blood       Date:  2010-03-05       Impact factor: 22.113

Review 3.  Cell fusion as a hidden force in tumor progression.

Authors:  Xin Lu; Yibin Kang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

4.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

Authors:  R W Storms; A P Trujillo; J B Springer; L Shah; O M Colvin; S M Ludeman; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  Stem cell regulation by the hematopoietic stem cell niche.

Authors:  David N Haylock; Susan K Nilsson
Journal:  Cell Cycle       Date:  2005-10-27       Impact factor: 4.534

6.  Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.

Authors:  Rama Adikrisna; Shinji Tanaka; Shunsuke Muramatsu; Arihiro Aihara; Daisuke Ban; Takanori Ochiai; Takumi Irie; Atsushi Kudo; Noriaki Nakamura; Shoji Yamaoka; Shigeki Arii
Journal:  Gastroenterology       Date:  2012-04-14       Impact factor: 22.682

Review 7.  Current advances in humanized mouse models.

Authors:  Ryoji Ito; Takeshi Takahashi; Ikumi Katano; Mamoru Ito
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

8.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

9.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

10.  EZH2 is essential for glioblastoma cancer stem cell maintenance.

Authors:  Mario-Luca Suvà; Nicolò Riggi; Michalina Janiszewska; Ivan Radovanovic; Paolo Provero; Jean-Christophe Stehle; Karine Baumer; Marie-Aude Le Bitoux; Denis Marino; Luisa Cironi; Victor E Marquez; Virginie Clément; Ivan Stamenkovic
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more
  73 in total

1.  Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.

Authors:  Suguru Hayase; Yoshihito Sasaki; Tsutomu Matsubara; Daekwan Seo; Masaaki Miyakoshi; Tsubasa Murata; Takashi Ozaki; Kennichi Kakudo; Kensuke Kumamoto; Kris Ylaya; Sheue-yann Cheng; Snorri S Thorgeirsson; Stephen M Hewitt; Jerrold M Ward; Shioko Kimura
Journal:  Thyroid       Date:  2015-03-23       Impact factor: 6.568

2.  Wogonin Influences Osteosarcoma Stem Cell Stemness Through ROS-dependent Signaling.

Authors:  Hyebin Koh; Hu-Nan Sun; Zhen Xing; Ren Liu; Nisansala Chandimali; Taeho Kwon; Dong-Sun Lee
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 3.  Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.

Authors:  Lan Zhang; Xupeng Tong; Jingjing Li; Yue Huang; Xinyue Hu; Yi Chen; Jian Huang; Jinhui Wang; Bo Liu
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

4.  New Born Calf Serum Can Induce Spheroid Formation in Breast Cancer KAIMRC1 Cell Line.

Authors:  Rizwan Ali; Sarah Huwaizi; Alshaimaa Alhallaj; Arwa Al Subait; Tlili Barhoumi; Hajar Al Zahrani; Abdullah Al Anazi; Abdul Latif Khan; Mohamed Boudjelal
Journal:  Front Mol Biosci       Date:  2021-12-24

5.  Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Authors:  Jacek R Wilczyński; Marek Nowak
Journal:  Exp Suppl       Date:  2022

6.  Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Authors:  Luisa Vicari; Cristina Colarossi; Dario Giuffrida; Ruggero De Maria; Lorenzo Memeo
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

7.  A filter-flow perspective of haematogenous metastasis offers a non-genetic paradigm for personalised cancer therapy.

Authors:  Jacob G Scott; Alexander G Fletcher; Philip K Maini; Alexander R A Anderson; Philip Gerlee
Journal:  Eur J Cancer       Date:  2014-10-08       Impact factor: 9.162

8.  Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer.

Authors:  Etna Abad; Yoelsis García-Mayea; Cristina Mir; David Sebastian; Antonio Zorzano; David Potesil; Zbynek Zdrahal; Alex Lyakhovich; Matilde E Lleonart
Journal:  Mol Cell Proteomics       Date:  2018-10-29       Impact factor: 5.911

Review 9.  Immuno-Oncolytic Viruses: Emerging Options in the Treatment of Colorectal Cancer.

Authors:  Sadia Islam Kana; Karim Essani
Journal:  Mol Diagn Ther       Date:  2021-03-12       Impact factor: 4.074

10.  Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation.

Authors:  Fahimeh Fattahi; Jafar Kiani; Mahdi Alemrajabi; Ahmadreza Soroush; Marzieh Naseri; Mohammad Najafi; Zahra Madjd
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.